Livio Susin - 08 Feb 2023 Form 3 Insider Report for Lucy Scientific Discovery, Inc.

Role
Director
Signature
/s/ Brian Zasitko, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Feb 2023
Net transactions value
$0
Form type
3
Filing time
09 Feb 2023, 09:36:18 UTC
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LSDI Common Shares 125,500 08 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LSDI Stock Option (right to buy) 08 Feb 2023 Common Shares 25,000 $1.73 Direct F1
holding LSDI Convertible Note 08 Feb 2023 Common Shares $21,965 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion price was converted from Canadian dollars to US dollars based on the noon rate of US$1.00 = CAD$1.2806 on December 28, 2020.
F2 Pursuant to a debt settlement agreement between the issuer and the reporting person, the note is convertible into common shares automatically upon the closing of the issuer's initial public offering at a 40% discount to the initial offering price.
F3 Represents the principal amount of the convertible note and excludes interest that may accrue. Interest on the convertible note is payable annually, in cash or common shares, at the holder's discretion.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney